Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study
Authors
Keywords
-
Journal
Dermatologic Therapy
Volume 2023, Issue -, Pages 1-5
Publisher
Hindawi Limited
Online
2023-10-27
DOI
10.1155/2023/1793535
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study
- (2022) Marco Galluzzo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
- (2022) Marco Galluzzo et al. Journal of Clinical Medicine
- Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature
- (2022) G. Licata et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis
- (2022) Alan Menter et al. Dermatology and Therapy
- Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks
- (2022) Luca Mastorino et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Scalp Psoriasis: A Literature Review of Effective Therapies and Updated Recommendations for Practical Management
- (2021) Megan Mosca et al. Dermatology and Therapy
- Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: A single‐center retrospective comparative study
- (2021) Alessandra Narcisi et al. Dermatologic Therapy
- A head‐to‐head comparison of risankizumab and ixekizumab for genital psoriasis: a real‐life, 24‐week, prospective study
- (2021) E. Sotiriou et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials
- (2020) Boni Elewski et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience
- (2020) M.C. Fargnoli et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pruritus characteristics in a large Italian cohort of psoriatic patients
- (2019) Giovanni Damiani et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases
- (2019) Andreas Pinter et al. JOURNAL OF DERMATOLOGY
- Sustained Efficacy of Secukinumab in Subjects with Moderate‐to‐Severe Palmoplantar Psoriasis: 2·5‐Year Results from GESTURE , a Randomized, Double‐blind, Placebo‐controlled Trial
- (2019) A.B. Gottlieb et al. BRITISH JOURNAL OF DERMATOLOGY
- A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now